The hepatotoxic effects of conventional drugs are well recognised, but herbal medicines are often assumed to be harmless and are advertised as such. The error of this assumption has recently received attention in the press,' but we think that doctors are not sufficiently aware of the potential toxicity of herbal medicines. We report on four women, three from Edinburgh and one from Tyneside, who sustained liver damage after taking herbal medicines for relieving stress. All had been in good health previously; none could recollect having been in contact with jaundice or hepatitis; none had travelled abroad, or had abused drugs parenterally or otherwise, or had been given blood or blood products; and none took alcohol in excess. Plasma bilirubin concentration and alanine transaminase activity on admission and during six months' follow up after taking herbal medicine (Neurelax) (case 1) the gall bladder with no dilatation of the bile ducts. Liver biopsy disclosed severe acute hepatitis with centrilobular and bridging necrosis. After stopping the herbal tablets her liver function test results subsequently returned to normal over the following three months. CASE 3 A 41 year old woman presented with jaundice, dark urine, and pale stools; she had been unwell for two months. She had taken a low dose contraceptive pill for five years without ill effects and four Kalms tablets daily for the previous three weeks. She had taken a course of Kalms tablets nine months previously but had had to stop because of nausea. She did not have a history of alcohol abuse. On examination she was jaundiced with no stigmata of chronic liver disease; an abdominal examination showed no abnormality. An isotopic liver scan was normal. Liver biopsy disclosed moderately active acute hepatitis. She stopped taking the tablets and, two months later, felt completely well; her liver function test results had returned to normal. CASE 4 A 42 year old woman presented with jaundice, nausea, and right hypochondrial pain. She had taken one Kalms tablet daily for three days a fortnight before. Alcohol abuse was not suspected. On examination she was icteric and did not have a fever or stigmata of chronic liver disease. Ultrasonography showed no abnormality, and liver biopsy was unsuccessful. She stopped taking the tablets and her jaundice resolved within weeks. The results of the other liver function tests, however, took nineteen months to return to normal values.
Discussion
We think it important that these four women had taken similar herbal medicines before their hepatic illnesses, for which no other cause could be found. The two preparations implicated (Kalms and Neurelax) are sold in health shops for relieving stress The question raises issues regarding the ease of transmission of hepatitis B virus within the family. The virus is not easily transmitted by casual, nonsexual contact or by sharing household items such as linen and towels. Prudence dictates that crockery and cutlery should be washed in boiling water with detergent. Transmission usually requires blood to blood contact. Sharing of abrasive items such as toothbrushes, razors, and other sharp objects must be avoided. Gloves must be worn while cleaning any spillages of blood or other infectious body fluids, which should be absorbed into disposable paper towels soaked in bleach (sodium hypochlorite) that are then incinerated in sealed plastic bags. In view of the slight risk of transmission within a family all regular contacts, especially children, should be screened for serological markers of hepatitis B virus infection (hepatitis B surface antigen and antibodies to hepatitis B core antigen and hepatitis B surface antigen) and susceptible seronegative individuals should be vaccinated against hepatitis B.' Vertical transmission from mother to child is common so other siblings as well as the mother should be screened. If the son is in one of the high risk groups for hepatitis B virus infection, such as homosexuals or intravenous drug abusers, this will raise social issues for the family.
The term "carrier" is most commonly applied to a symptomless person who is positive for hepatitis B surface antigen. This is misleading because long term persistence of the antigen in the serum, even in asymptomatic subjects, can be associated with the development of chronic liver disease, cirrhosis, and primary liver cancer. Antiviral treatment with interferons can now achieve clearance of hepatitis B surface antigen and e antigen in 30-40% of carriers. Serum hepatitis B virus DNA, a measure of active viral replication, should be sought because this reflects progression of the liver disease as well as the potential risk of infection. Liver histology is useful for prognosis. -ROGER WILLIAMS, consultant physician, London
